Testing effectiveness (Phase 2)Study completedNCT03485144What this trial is testingA Clinical Study to Evaluate TV003 in Healthy Adults in TaiwanWho this might be right forDengue Medigen Vaccine Biologics Corp. 54
Large-scale testing (Phase 3)Study completedNCT01352845What this trial is testingA Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.Who this might be right forHealthy Pfizer 3,301
Testing effectiveness (Phase 2)Study completedNCT03190265What this trial is testingStudy of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 61
Testing effectiveness (Phase 2)Study completedNCT00886964What this trial is testingHepatitis B Vaccination (HBV) in HIV Infected ChildrenWho this might be right forHIV Infections The HIV Netherlands Australia Thailand Research Collaboration 80
Testing effectiveness (Phase 2)Study completedNCT01974206What this trial is testingEvaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive DonorWho this might be right forKidney Transplantation Cytomegalovirus (CMV) Negative Recipients Astellas Pharma Global Development, Inc. 150
Not applicableLooking for participantsNCT06676644What this trial is testingEstimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted VaccinesWho this might be right forInfluenza VaccinesElderly National Taiwan University Hospital 200
Large-scale testing (Phase 3)Study completedNCT05543616What this trial is testingLearn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenWho this might be right forSARS-CoV-2 VirusSevere Acute Respiratory Syndrome Coronavirus 2COVID-19 BioNTech SE 4,338
Testing effectiveness (Phase 2)Study completedNCT04380701What this trial is testingA Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised AdultsWho this might be right forInfections, RespiratoryVirus DiseasesInfection Viral+3 more BioNTech SE 512
Large-scale testing (Phase 3)Study completedNCT01203319What this trial is testingThe Immunogenicity and Safety of 60mcg/30mcg Recombinant Hepatitis B Vaccines in People Who Failed to Respond to Routine Administration of Hepatitis B VaccinesWho this might be right forHepatitis b Jiangsu Province Centers for Disease Control and Prevention 1,091
Testing effectiveness (Phase 2)Study completedNCT00352898What this trial is testingImmunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™Who this might be right forMumpsRubellaMeasles+1 more GlaxoSmithKline 400
Early research (Phase 1)Study completedNCT00455221What this trial is testingSafety Assessment of a Multipeptide-gene Vaccine in CMLWho this might be right forLeukemia, Myeloid, Chronic Tehran University of Medical Sciences 12
Early research (Phase 1)Study completedNCT03783130What this trial is testingDose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy AdultsWho this might be right forHuman Immunodeficiency Virus PreventionHuman Immunodeficiency Virus (HIV) National Institute of Allergy and Infectious Diseases (NIAID) 16
Large-scale testing (Phase 3)Study completedNCT02955797What this trial is testingImmunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in ToddlersWho this might be right forMeningitisMeningococcal MeningitisMeningococcal Infections Sanofi Pasteur, a Sanofi Company 918
Early research (Phase 1)Looking for participantsNCT06799013What this trial is testingSafety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic FeverWho this might be right forVaccineCrimean-Congo Hemorrhagic Fever HDT Bio 48
Testing effectiveness (Phase 2)Study completedNCT00880698What this trial is testingSafety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected MothersWho this might be right forHIV InfectionRotavirus Infection National Institute of Allergy and Infectious Diseases (NIAID) 202
Large-scale testing (Phase 3)Study completedNCT00511914What this trial is testingSafety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008Who this might be right forSeasonal Influenza Vaccine Novartis Vaccines 135
Early research (Phase 1)Study completedNCT01829490What this trial is testingSafety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy AdultsWho this might be right forTuberculosis University of Oxford 42
Large-scale testing (Phase 3)Study completedNCT06015282What this trial is testingThe Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and OlderWho this might be right forInfluenza, Human Seqirus 7,741
Early research (Phase 1)Ended earlyNCT04299724What this trial is testingSafety and Immunity of Covid-19 aAPC VaccineWho this might be right forTreat and Prevent Covid-19 Infection Shenzhen Geno-Immune Medical Institute 100
Early research (Phase 1)Study completedNCT00026624What this trial is testingSafety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SCWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)